Drugs / DR-1021
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00544882 | Oct 2007 → Mar 2008 | — | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00362479 | Aug 2006 → Jul 2007 | — | Duramed Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-1021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00544882 ↗ |
| Route | Oral | “6 months of oral contraceptive therapy with DR-1021” NCT00362479 ↗ |